There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...
A new study led by University of Manchester scientists has identified genetic variants that make some patients more sensitive ...
5don MSN
New imaging solution could help improve survival for patients with recurring prostate cancer
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...
News-Medical.Net on MSN
New imaging technique boosts survival in prostate cancer patients
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...
Wellbeing Whisper on MSN
Biden Undergoes Radiation and Hormone Therapy for Aggressive Prostate Cancer
A Gleason score of 9.” Veterans of prostate cancer will know those five words pack a punch. It is a grade-high diagnosis, ...
That’s because most cases are caught before the cancer has spread. In fact, more than 75% of diagnoses are made while the disease is still confined to the prostate. When that happens, the outlook is ...
Consultant urological surgeon Prof Nikhil Vasdev outlines what you should know about the second-most common cause of cancer ...
“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback